ORASURE TECHNOLOGIES INC (OSUR) Stock Price, Quote, News and Overview
NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD
OSUR Quote, Performance and Key Statistics
3.8
-0.08 (-2.06%)
The current stock price of OSUR is 3.8 USD. In the past month the price decreased by -4.76%. In the past year, price decreased by -45.4%.
OSUR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.9 | 45.13B | ||
| COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
| SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
| BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
| ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
| XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
| HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
| NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
| UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
Related stock screener links
About OSUR
Company Profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 638 full-time employees. The firm's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Company Info
ORASURE TECHNOLOGIES INC
220 E First St
Bethlehem PENNSYLVANIA 18015 US
CEO: Stephen S. Tang
Employees: 638
Company Website: https://www.orasure.com/
Investor Relations: https://orasure.gcs-web.com/
Phone: 15036416115
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the stock price of ORASURE TECHNOLOGIES INC today?
The current stock price of OSUR is 3.8 USD. The price decreased by -2.06% in the last trading session.
What is the ticker symbol for ORASURE TECHNOLOGIES INC stock?
The exchange symbol of ORASURE TECHNOLOGIES INC is OSUR and it is listed on the Nasdaq exchange.
On which exchange is OSUR stock listed?
OSUR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ORASURE TECHNOLOGIES INC stock?
11 analysts have analysed OSUR and the average price target is 4.59 USD. This implies a price increase of 20.79% is expected in the next year compared to the current price of 3.8. Check the ORASURE TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ORASURE TECHNOLOGIES INC worth?
ORASURE TECHNOLOGIES INC (OSUR) has a market capitalization of 283.44M USD. This makes OSUR a Micro Cap stock.
How many employees does ORASURE TECHNOLOGIES INC have?
ORASURE TECHNOLOGIES INC (OSUR) currently has 638 employees.
What are the support and resistance levels for ORASURE TECHNOLOGIES INC (OSUR) stock?
ORASURE TECHNOLOGIES INC (OSUR) has a support level at 3.78 and a resistance level at 3.83. Check the full technical report for a detailed analysis of OSUR support and resistance levels.
Is ORASURE TECHNOLOGIES INC (OSUR) expected to grow?
The Revenue of ORASURE TECHNOLOGIES INC (OSUR) is expected to decline by -53.91% in the next year. Check the estimates tab for more information on the OSUR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ORASURE TECHNOLOGIES INC (OSUR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OSUR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OSUR, evaluating the profitability, health, valuation and growth aspects
- ORASURE TECHNOLOGIES INC (OSUR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ORASURE TECHNOLOGIES INC (OSUR) Sales and EPS estimates to see what analysts future expectations are.
- ORASURE TECHNOLOGIES INC (OSUR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ORASURE TECHNOLOGIES INC (OSUR) Insider and Institutional Ownership to learn about the owners and their transactions.
- ORASURE TECHNOLOGIES INC (OSUR) Stock Chart to make your own analysis
- ORASURE TECHNOLOGIES INC (OSUR) Latest news and press-releases to stay up to date.
Does ORASURE TECHNOLOGIES INC (OSUR) stock pay dividends?
OSUR does not pay a dividend.
When does ORASURE TECHNOLOGIES INC (OSUR) report earnings?
ORASURE TECHNOLOGIES INC (OSUR) will report earnings on 2025-02-25, after the market close.
What is the Price/Earnings (PE) ratio of ORASURE TECHNOLOGIES INC (OSUR)?
The PE ratio for ORASURE TECHNOLOGIES INC (OSUR) is 25.33. This is based on the reported non-GAAP earnings per share of 0.15 and the current share price of 3.8 USD. Check the full fundamental report for a full analysis of the valuation metrics for OSUR.
What is the Short Interest ratio of ORASURE TECHNOLOGIES INC (OSUR) stock?
The outstanding short interest for ORASURE TECHNOLOGIES INC (OSUR) is 2.64% of its float. Check the ownership tab for more information on the OSUR short interest.
OSUR Technical Analysis
OSUR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to OSUR. No worries on liquidiy or solvency for OSUR as it has an excellent financial health rating, but there are worries on the profitability.
OSUR Financial Highlights
Over the last trailing twelve months OSUR reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS decreased by -81.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.07% | ||
| ROA | 2.45% | ||
| ROE | 2.67% | ||
| Debt/Equity | 0 |
OSUR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to OSUR. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -120.48% and a revenue growth -53.91% for OSUR